These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 27308804)

  • 1. Prevention of Mother-to-Child Transmission of HIV in Option B+ Era: Uptake and Adherence During Pregnancy in Western Uganda.
    Schnack A; Rempis E; Decker S; Braun V; Rubaihayo J; Busingye P; Tumwesigye NM; Harms G; Theuring S
    AIDS Patient Care STDS; 2016 Mar; 30(3):110-8. PubMed ID: 27308804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
    Omonaiye O; Kusljic S; Nicholson P; Manias E
    BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.
    Lumbantoruan C; Kermode M; Giyai A; Ang A; Kelaher M
    PLoS One; 2018; 13(6):e0198329. PubMed ID: 29912960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delays, interruptions, and losses from prevention of mother-to-child transmission of HIV services during antenatal care in Johannesburg, South Africa: a cohort analysis.
    Schnippel K; Mongwenyana C; Long LC; Larson BA
    BMC Infect Dis; 2015 Feb; 15():46. PubMed ID: 25656597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
    Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'I fear my partner will abandon me': the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda.
    Alhassan Y; Twimukye A; Malaba T; Myer L; Waitt C; Lamorde M; Colbers A; Reynolds H; Khoo S; Taegtmeyer M
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):566. PubMed ID: 35840939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study.
    Mukose AD; Bastiaens H; Makumbi F; Buregyeya E; Naigino R; Musinguzi J; Van Geertruyden JP; Wanyenze RK
    PLoS One; 2021; 16(5):e0251181. PubMed ID: 33951109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.
    Maskew M; Jamieson L; Mohomi G; Long L; Mongwenyana C; Nyoni C; Mokaba D; Fox MP; Sanne I; Rosen S
    PLoS One; 2018; 13(8):e0201955. PubMed ID: 30161147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of mother-to-child transmission of HIV in rural Uganda: modelling effectiveness and impact of scaling-up PMTCT services.
    Larsson EC; Ekström AM; Pariyo G; Tomson G; Sarowar M; Baluka R; Galiwango E; Thorson AE
    Glob Health Action; 2015; 8():26308. PubMed ID: 25726836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of mother-to-child transmission of HIV: Postpartum adherence to Option B+ until 18 months in Western Uganda.
    Decker S; Rempis E; Schnack A; Braun V; Rubaihayo J; Busingye P; Tumwesigye NM; Harms G; Theuring S
    PLoS One; 2017; 12(6):e0179448. PubMed ID: 28662036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+).
    van Lettow M; Bedell R; Mayuni I; Mateyu G; Landes M; Chan AK; van Schoor V; Beyene T; Harries AD; Chu S; Mganga A; van Oosterhout JJ
    J Int AIDS Soc; 2014; 17(1):18994. PubMed ID: 25079437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake and performance of prevention of mother-to-child transmission and early infant diagnosis in pregnant HIV-infected women and their exposed infants at seven health centres in Addis Ababa, Ethiopia.
    Girma M; Wendaferash R; Shibru H; Berhane Y; Hoelscher M; Kroidl A
    Trop Med Int Health; 2017 Jun; 22(6):765-775. PubMed ID: 28407452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
    Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
    BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation and Operational Research: Integration of PMTCT and Antenatal Services Improves Combination Antiretroviral Therapy Uptake for HIV-Positive Pregnant Women in Southern Zambia: A Prototype for Option B+?
    Herlihy JM; Hamomba L; Bonawitz R; Goggin CE; Sambambi K; Mwale J; Musonda V; Musokatwane K; Hopkins KL; Semrau K; Hammond EE; Duncan J; Knapp AB; Thea DM
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):e123-9. PubMed ID: 26181813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the acceptability of Option B plus among HIV-positive Nigerian women engaged and not engaged in the prevention of mother-to-child transmission of HIV cascade: a qualitative study.
    Erekaha SC; Cornelius LJ; Bessaha ML; Ibrahim A; Adeyemo GD; Fadare M; Charurat M; Ezeanolue EE; Sam-Agudu NA
    SAHARA J; 2018 Dec; 15(1):128-137. PubMed ID: 30253709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards elimination of mother-to-child transmission of HIV in Ghana: an analysis of national programme data.
    Dako-Gyeke P; Dornoo B; Ayisi Addo S; Atuahene M; Addo NA; Yawson AE
    Int J Equity Health; 2016 Jan; 15():5. PubMed ID: 26759248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of "prevention of mother-to-child transmission" of HIV services by adolescent and young mothers in Mulago Hospital, Uganda.
    Mustapha M; Musiime V; Bakeera-Kitaka S; Rujumba J; Nabukeera-Barungi N
    BMC Infect Dis; 2018 Nov; 18(1):566. PubMed ID: 30428835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient and provider perspectives on improving the linkage of HIV-positive pregnant women to long-term HIV care and treatment in eastern Uganda.
    Saleem H; Kyeyagalire R; Lunsford SS
    Afr J AIDS Res; 2014; 13(1):45-51. PubMed ID: 25174515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda.
    Rempis EM; Schnack A; Decker S; Braun V; Rubaihayo J; Tumwesigye NM; Busingye P; Harms G; Theuring S
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):82. PubMed ID: 28270119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal utilization of prevention of mother-to-child transmission of HIV services among adolescents under group versus focused antenatal care in Eastern Uganda.
    Akunzirwe R; Bakeera-Kitaka S; Kalyango JN; Zalwango JF; Ssemasaazi JA; Okello T; Buhuguru R; Kiguli S; Mubuuke AG; Ononge S
    PLoS One; 2022; 17(11):e0275905. PubMed ID: 36318523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.